995
Views
3
CrossRef citations to date
0
Altmetric
Editorial

How to improve the survival of the kidney transplant – is it only the pharmaceutical management?

&

Bibliography

  • Spasovski G, Vanholder R. Kidney transplantation in emerging countries: do we know all issues? Minerva Urol Nefrol 2012;64:183-9
  • Hofer J, Regele H, Böhmig GA, et al. Pre-implant biopsy predicts outcome of single-kidney transplantation independent of clinical donor variables. Transplantation 2014;97(4):426-32
  • Fehr T, Stussi G. ABO-incompatible kidney transplantation. Curr Opin Organ Transplant 2012;17:376-85
  • Pérez-Flores I, Santiago JL, Calvo-Romero N, et al. Different impact of pretransplant anti-HLA antibodies detected by luminex in highly sensitized renal transplanted patients. Biomed Res Int 2013;2013:738404
  • Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant 2009;9:35-41
  • Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004;4:378-83
  • Schaefer SM, Süsal C, Sommerer C, et al. Current pharmacotherapeutical options for the prevention of kidney transplant rejection. Expert Opin Pharmacother 2013;14:1029-41
  • Moreso F, Hernández D. Has the survival of the graft improved after renal transplantation in the era of modern immunosuppression? Nefrologia 2013;33:14-26
  • Lebranchu Y, Baan C, Biancone L, et al. Pre-transplant identification of acute rejection risk following kidney transplantation. Transpl Int 2014;27(2):129-38
  • Opelz G, Döhler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007;84(2):137-43
  • Sellarés J, de Freitas DG, Mengel M, et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012;12:388-99
  • Dunn TB, Noreen H, Gillingham K, et al. Revisiting traditional risk factors for rejection and graft loss after kidney transplantation. Am J Transplant 2011;11:2132-43
  • Pascual J, Royuela A, Galeano C, et al. Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review. Nephrol Dial Transplant 2012;27:825-32
  • Chung BH, Choi BS, Oh EJ, et al. Clinical impact of the baseline donor-specific anti-human leukocyte antigen antibody measured by luminex single antigen assay in living donor kidney transplant recipients after desensitization therapy. Transpl Int 2014;27:49-59
  • Dörje C, Midtvedt K, Holdaas H, et al. Early versus late acute antibody-mediated rejection in renal transplant recipients. Transplantation 2013;96:79-84

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.